Literature DB >> 19119462

Primary large cell neuroendocrine carcinoma of the breast: radiologic and pathologic findings.

Jin Woo Kim1, Ok Hee Woo, Kyu Ran Cho, Bo Kyung Seo, Hwan Seok Yong, Aeree Kim, Eun-Young Kang.   

Abstract

Some breast neoplasms are classified as primary neuroendocrine carcinomas because they are positive for neuroendocrine markers. Although neuroendocrine carcinomas can originate from various organs of the body, primary neuroendocrine carcinomas of the breast are extremely rare. The diagnosis of primary neuroendocrine carcinoma of the breast can only be made if nonmammary sites are confidently excluded or if an in situ component can be found. Here we report a primary large-cell neuroendocrine carcinoma (LCNL) involving the left breast. Breast ultrasonography revealed a lobulated, heterogeneous, low-echoic mass in the left breast, and the lesion appeared as a well-defined, highly-enhancing mass on a chest computed tomography scan. Ultrasound-guided core needle biopsy was performed on the mass, and primary LCNC was confirmed by histopathologic examination.

Entities:  

Keywords:  Breast; Large Cell Neuroendocrine Carcinoma; Tomography, X-Ray Computed; Ultrasonography

Mesh:

Year:  2008        PMID: 19119462      PMCID: PMC2610652          DOI: 10.3346/jkms.2008.23.6.1118

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  10 in total

Review 1.  Expression of the neuroendocrine phenotype in carcinomas of the breast.

Authors:  A Sapino; L Righi; P Cassoni; M Papotti; F Pietribiasi; G Bussolati
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

2.  Primary oat cell carcinoma of the breast: imaging features.

Authors:  Antonio Mariscal; Elda Balliu; Rocío Díaz; J Darío Casas; Ana María Gallart
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

3.  Primary alveolar-type large cell neuroendocrine carcinoma of the breast.

Authors:  Wen-Chiuan Tsai; Jyh-Cherng Yu; Chih-Kung Lin; Cheng-Ta Hsieh
Journal:  Breast J       Date:  2005 Nov-Dec       Impact factor: 2.431

4.  Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.

Authors:  M Papotti; L Macrì; G Finzi; C Capella; V Eusebi; G Bussolati
Journal:  Semin Diagn Pathol       Date:  1989-05       Impact factor: 3.464

Review 5.  Large cell neuroendocrine cervical carcinoma: a report of two cases and review of the literature.

Authors:  T C Krivak; J W McBroom; M J Sundborg; B Crothers; M F Parker
Journal:  Gynecol Oncol       Date:  2001-07       Impact factor: 5.482

6.  Neuroendocrine differentiated breast carcinoma: imaging features correlated with clinical and histopathological findings.

Authors:  Isil Günhan-Bilgen; Osman Zekioglu; Esin Emin Ustün; Aysenur Memis; Yildiz Erhan
Journal:  Eur Radiol       Date:  2002-08-14       Impact factor: 5.315

7.  Management of neuroendocrine differentiated breast carcinoma.

Authors:  A Berruti; A Saini; E Leonardo; S Cappia; P Borasio; L Dogliotti
Journal:  Breast       Date:  2004-12       Impact factor: 4.380

8.  Neuroendocrine differentiation and prognosis in breast adenocarcinoma.

Authors:  A Miremadi; S E Pinder; A H S Lee; J A Bell; E C Paish; P Wencyk; C W Elston; R I Nicholson; R W Blamey; J F Robertson; I O Ellis
Journal:  Histopathology       Date:  2002-03       Impact factor: 5.087

9.  Neuroendocrine differentiated carcinomas of the breast: a distinct entity.

Authors:  Osman Zekioglu; Yíldíz Erhan; Metin Ciriş; Hatice Bayramoglu
Journal:  Breast       Date:  2003-08       Impact factor: 4.380

Review 10.  Carcinomas of the breast with endocrine differentiation: a review.

Authors:  H M Maluf; F C Koerner
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

  10 in total
  9 in total

1.  Primary Neuroendocrine Carcinoma of the Breast: A Report of Three Cases.

Authors:  Faruk Aksoy; Ebubekir Gündeş; Celalettin Vatansev; Murat Çakır; Hatice Toy; Ganime Dilek Emlik
Journal:  J Breast Health       Date:  2014-04-01

2.  A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysis.

Authors:  Yu-Qiu Chen; Xiao-Fan Xu; Jia-Wei Xu; Tian-Yu Di; Xu-Lin Wang; Li-Qun Huo; Lu Wang; Jun Gu; Guo-Hua Zhou
Journal:  Transl Oncol       Date:  2022-06-11       Impact factor: 4.803

3.  Primary Neuroendocrine Carcinoma of the Breast with Clinical Features of Inflammatory Breast Carcinoma: A Case Report and Literature Review.

Authors:  Do Hyung Lee; Ah Young Park; Bo Kyoung Seo; Young Sik Kim; Ki Yeol Lee; Sang Hoon Cha
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

4.  Primary Large-Cell Neuroendocrine Carcinoma of the Breast Occurring in a Pre-Menopausal Woman.

Authors:  Noriko Yoshimura; Tatsunari Sasada; Shuji Yonehara
Journal:  Breast Care (Basel)       Date:  2015-05-29       Impact factor: 2.860

5.  Primary neuroendocrine breast carcinoma: a case report and literature review.

Authors:  Maria Helena Valentim; Vanessa Monteiro; José Carlos Marques
Journal:  Radiol Bras       Date:  2014 Mar-Apr

Review 6.  [Neuroendocrine carcinoma of the breast: about a case and review of the literature].

Authors:  Mariam Affane; Leila Elmorjani; Abdelhamid El Omrani; Fayçal Abbadi; Hanane Rais; Mouna Khouchani
Journal:  Pan Afr Med J       Date:  2016-05-24

7.  [Primary large cell neuroendocrine carcinoma of the breast: a rare tumor in humans].

Authors:  Fatima Safini; Zineb Bouchbika; Zineb Bennani; Sara Belkheiri; Hicham El Attar; Nadia Benchakroun; Hassan Jouhadi; Nezha Tawfiq; Souha Sahraoui; Abdellatif Benider
Journal:  Pan Afr Med J       Date:  2016-11-29

8.  Primary neuroendocrine carcinoma of the breast: report of 2 cases and literature review.

Authors:  Fernando Collado-Mesa; Jose M Net; Geetika A Klevos; Monica M Yepes
Journal:  Radiol Case Rep       Date:  2017-01-05

9.  Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.

Authors:  Fernando A Angarita; Jorge L Rodríguez; Eugenio Meek; Jesus O Sánchez; Mauricio Tawil; Lilian Torregrosa
Journal:  World J Surg Oncol       Date:  2013-06-05       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.